London Biotechnology Show to Unveil Cutting-edge Advances in Health & Medicine

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its debut. This upcoming #LBS25 scheduled from 18 - 19 June 2025 has significantly expanded its scope, offering an even richer array of content, product showcases, and innovations.

The inaugural London Biotechnology Show in 2024 was a major hit with over 3,000 attendees present at the event, including representatives from 1,500 companies, 70+ sponsors and exhibitors, 60+ speakers, 30+ media partners, and other key stakeholders. Prominent speakers from companies such as Microsoft, the UK Health Security Agency, AltruBio Inc., Axia Medicine, AstraZeneca, Eli Lilly and Company, Roche, MENARINI Group, Deep Science Ventures etc. contributed to making the first edition a major success.

Additionally, 70 regional and global exhibitors showcased cutting-edge products and services, ranging from established names like Discovery Park, Agilent Technologies, Aramex, Phaidon International, NHS Innovation Service, Merck Life Science, Thermo Fisher and many more. The expo provided a glimpse into the future of biotechnology, highlighting how technology is set to revolutionize healthcare and medical sectors worldwide. Meanwhile, the presence of esteemed media entities like the BBC, Associated Press, Bloomberg, Newsweek, Wired, Globaldata, and Raconteur further amplified the event's global reach and impact.

Building on the success of its previous edition, #LBS25 has already made a remarkable kickoff, with many sponsors and exhibitors having secured their spots again. This year's show boasts a substantial floor plan of 4000 square meters, featuring the latest products, services, and innovations from both leading companies and startups. Notable names already registered for this year’s show include, Stratagem IPM, LI-Cor Bioscience Ltd., Restore Harrow Green, NIHR, LAUDA Technology, Carterra, ProteoGenix, Life4sciences, Bishop Simon, LS Scientific, Haier Biomedical UK Ltd., Ellab, Discovery Park, and Cool Repair System, among others.

Understanding the pivotal importance of networking and collaboration in driving the industry forward, one of the important highlights of #LBS25 is Hosted Buyer Programme, which will serve as an ideal platform for connecting buyers seamlessly with participating sponsors and exhibitors to help build an invaluable network for their brand, through the power of pre-arranged one-to-one meetings matched for them.

To enlighten an enthused audience, #LBS25 has also built an impressive speaker line-up. Some of the important names who have confirmed their participation include, Andrew Miles, Multicultural Executive & Leader in Life Sciences and Technology, Google | Jakob E. Larsen, Target Discovery Project Director, Novo Nordisk | Thomas Balkizas, Senior Director Life Sciences, Microsoft | Dr Nicole Mather, Health & Life Sciences Leader, IBM | Rohit Dayama, Client Partner, Life Sciences, Cognizant | Dr James Duboff, Strategic Partnerships Director, Genomics England | Mark Davies, Chief Health Officer, IBM | Prof. Zulfiqur Ali, Director, Academic Research and Innovation Partnerships, Teesside University | Professor Jon Dawson, Director of the Centre for Human Development, Stem Cells and Regeneration, University of Southampton | Dr. Sharib Ali, Lecturer/Researcher in AI for Healthcare (Medicine and Surgery), University of Leeds | Prof. Darius Widera, Professor of Stem Cell Biology and Regenerative Medicine, University of Reading | Linh TB Nguyen, Lecturer in Biomaterials and Allied Subjects, UCL | Anna Wilbrey-Clark, Senior Staff Scientist, Wellcome Sanger Institute | Dr Stephen Ward, Chief Manufacturing Officer, Cell and Gene Therapy Catapult | Phil Brown, Director, Technical and Regulatory, Association of British Healthcare Industries Limited |Dace Dimza-Jones, National Life Sciences Investment Specialist, Department for Business & Trade | Dr. Bryn Roberts, Global Head of Data, Analytics & Research, Roche Information Solutions | Kingyin Lee, Head of Clinical Trials, Medicines and Healthcare products Regulatory Agency.

The conference promises to deliver thought-provoking keynote speeches, dynamic panel discussions, and interactive sessions, exploring a diverse array of cutting-edge topics in biotechnology. Attendees will have the opportunity to dive deep into critical areas such as gene editing, pharmaceuticals, regenerative medicine, agriculture, bioinformatics, and more.

Don't miss out on this opportunity to witness the future of biotechnology first-hand. Register Now and be a part of this spectacular showcase of innovation!  Your attendance at #LBS25 would not only provide you with unparalleled access to industry leaders and innovators but also offer a unique opportunity to delve into the latest advancements and trends in biotechnology.

For important queries, reach us at press@valiantandcompany.com or call us at 44 2032878878